Ceftazidime for peak identification EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
Journal of medical microbiology, 63(Pt 1), 56-65 (2013-10-04)
The mechanisms responsible for the increase in ceftazidime MIC in two Escherichia coli in vitro selected mutants, Caz/20-1 and Caz/20-2, were studied. OmpF loss and overexpression of acrB, acrD and acrF that were associated with acrR and marR mutations and
Antimicrobial agents and chemotherapy, 57(11), 5697-5700 (2013-08-14)
It is unclear whether the genetic background of drug-resistant Pseudomonas aeruginosa was disseminated from a certain clone. Thus, we performed MLST (multilocus sequence typing) of 896 P. aeruginosa isolates that were nonsusceptible to imipenem, meropenem, or ceftazidime. This revealed 254
Covalent trapping and bacterial resistance to ceftazidime.
Jean-Marie A Frère
The Journal of biological chemistry, 288(37), 26967-26967 (2013-09-17)
Journal of the American Veterinary Medical Association, 243(3), 424-429 (2013-07-20)
To determine the plasma disposition kinetics, absolute bioavailability, and milk concentrations of ceftazidime in healthy lactating female dromedary camels (Camelus dromedarius) following IV and IM administration of a single dose of 10 mg/kg (4.5 mg/lb). Prospective crossover study. 8 healthy
First outbreak of KPC-3-producing Klebsiella pneumoniae (ST258) clinical isolates in a Mexican Medical Center.
Patricia Rodríguez-Zulueta et al.
Antimicrobial agents and chemotherapy, 57(8), 4086-4088 (2013-06-05)
